CONCORD HC GP(02453): The application for the license to configure large medical equipment for proton therapy devices has been approved by the National Health Commission.

15/09/2024

GMT Eight

CONCORD HC GP (02453) announced that the company submitted an application for a license to operate proton therapy equipment to the National Health Commission of the People's Republic of China (NHC) on April 29, 2024. The board of directors is pleased to announce that the NHC approved the company's license application on September 13, 2024. The operation of proton therapy services will begin as soon as several deployments are completed. The company will provide more updated information on the significant progress of its planned proton therapy services in due course.

ABBISKO-B(02256): Hu Yu Pharmaceutical announced the latest clinical progress of ipatasertib and pimertinib at the ESMO Annual Meeting.

China Railway Construction Corporation (01186) plans to issue 3.5 billion yuan in bills through its subsidiary Tiejian Huayuan.

Contact: contact@gmteight.com

CONCORD HC GP(02453): The application for the license to configure large medical equipment for proton therapy devices has been approved by the National Health Commission.

RECOMMEND

The other side of the merger and reorganization wave: More than ten listed companies announced termination within the year, with semiconductor companies accounting for over 50%.

Haitong Strategy's 25-year outlook: improvement in both fundaments and A-shares continue their upward trend.

Cui Dongshu: The replacement policy for passenger cars has ignited the October car market, further benefiting new energy vehicles.